Quantifying mutated and unmutated BCR-ABL transcripts confirms suitability of direct sequencing sensitivity in mutation analysis of patients with chronic myeloid leukemia with secondary resistance to tyrosine kinase inhibitors, regardless of ratio values

dc.contributor.author	Santamaría Ruiz de Azúa, Íñigo
dc.contributor.author	Payer, Ángel R.
dc.contributor.author	Sánchez Pitiot, Ana Gloria
dc.contributor.author	González Alvarado, María Marta
dc.contributor.author	Balbín Felechosa, Milagros
dc.date.accessioned	2016-03-22T13:15:30Z
dc.date.available	2016-03-22T13:15:30Z
dc.date.issued	2010
dc.identifier.citation	Leukemia and Lymphoma, 51(2), p. 350-354 (2010); doi:10.3109/10428190903470349
dc.identifier.issn	1042-8194
dc.identifier.uri	http://hdl.handle.net/10651/35916
dc.format.extent	p. 350-354
dc.language.iso	eng
dc.relation.ispartof	Leukemia and Lymphoma
dc.rights	© 2010 Informa Healthcare USA
dc.source	Scopus
dc.source.uri	http://www.scopus.com/inward/record.url?eid=2-s2.0-76349116521&partnerID=40&md5=c1d731d42da4335ffb9dcc52dd74c6e6
dc.title	Quantifying mutated and unmutated BCR-ABL transcripts confirms suitability of direct sequencing sensitivity in mutation analysis of patients with chronic myeloid leukemia with secondary resistance to tyrosine kinase inhibitors, regardless of ratio values
dc.type	journal article
dc.identifier.doi	10.3109/10428190903470349
dc.relation.publisherversion	http://dx.doi.org/10.3109/10428190903470349

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.